Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals

Brand · Pharmaceutical Manufacturing

4.6

Company overview

Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Founded in 2017
Irvine, California, USA
383 employees (23 in marketing)
87% recommend to a friend
100% positive business outlook

Salaries

Typical salary range

$165,000 – $231,000

/ yr

Help build salary transparency at Tarsus Pharmaceuticals

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +12.2% year over year

Funding

Total funding

$710.6M

Last raise

$125M

Post IPO Equity, 1 years ago

Funding history

Mar 2025

Post IPO Equity Tarsus Pharmaceuticals · $125M

Apr 2024

Post IPO Debt Tarsus Pharmaceuticals · $75M

Feb 2024

Post IPO Equity Tarsus Pharmaceuticals · $100M

Jul 2023

Post IPO Equity Tarsus Pharmaceuticals · $100M

May 2022

Post IPO Equity Tarsus Pharmaceuticals · $75.6M

Jan 2022

Post IPO Debt Tarsus Pharmaceuticals · $175M

Audience

Monthly website visitors
38.3K
Month over month-7.9%
Quarter over quarter+32.8%
Top sourceDirect (44.2%)
Ad budget per month$267.6
Average search rank38.1
Traffic source mix
Direct
44.2%
Search
44.1%
Referral
7.8%
Social
2.1%
Paid referral
1.6%

LinkedIn followers

Follower count and growth

Total followers

33.7K

12-mo growth

+36.3%

Monthly growth

+4.9%

News

Links